Another study showed that CR (30 mg/kg) alleviated apoptosis, neurodegeneration, and enhanced protection in rotenone-induced Parkinson’s disease rats via mammalian target of rapamycin (mTOR) pathway activation (Salama et al., 2020). Here, MTOR is linked to Parkinson disease.